After participating in this educational activity, attendees should be able to:
1. Describe the roles of the members of the healthcare team in their respective responsibilities for quality care.
2. Discuss the MOA for SGCT2 inhibitors
3. Describe the benefits of SGCT2 inhibitors vs other DM meds
4. List the renal effects of SGCT2 inhibitors
Michael Germain, MD
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
Dr./Mr./Ms. XXX is a consultant for AA Pharmaceuticals, is on the Speaker'Bureau for BB Company, and is a Stock/Shareholder of ZZZ.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 BCIPE Instructional Hours